Letter From The Editor

Some of our patients are starting to get out more and hopefully getting more active. Now would be a great time to help guide them in the best exercises to get them going. This week our exercise guru Dr. Sheri Colberg shares core strengthening activities for your diabetes patients. ***************************** …

We have all heard the phrase “kill two birds with one stone,” but did you know that it originally came from the story of Daedalus and Icarus, who escaped from the Labyrinth on Crete by making wings and flying out? This story comes from Greek Mythology; we use it now …

The news about the corona virus can be overwhelming for the healthiest person, but if you have a disease like diabetes all you hear is how much more risk you have of serious complications. Typically the news feeds don’t fully explain the whole story and often only the worst is …

Over the past 5 years all of the SGLT-2 inhibitors have gotten various indications for cardiovascular protection. Now it appears that a drug used for Acute Coronary Syndrome can have very positive benefits in preventing and reversing diabetes. Check out this week’s feature from Chardae Whitner, 2020 PharmD. Candidate, Lake …

My good friend and owner of St. Pete Bike and Fitness, Mark Yeager, told me that April was the best month business-wise in his long history. He sells bikes costing as much as $13,000 (don’t ask me what mine cost), but most of the bikes he sold in his record …

Over the years we have published many articles on the pros and cons of statin therapy for diabetes patients. Doing a quick look on our website, I found we have over 400 articles on the topic and the pros and cons are split 60/40 in favor of using statins. I …

George McConnell, PharmD. Candidate, LECOM, has a special feature on the value of CGM versus HbA1c that points to the value of TIR and the use of TIR to uncover problems in patients with a close to perfect A1c. If you are not sure what TIR is, or how to …

Modern technology has made glucose management much easier for all patients and especially those using insulin. Although we typically think that everyone will like all the data and management tools CGM and pump technology offer, there can be an overload of information that creates undue stress for the patient. This …

If you look at studies from 40 years ago, there was always the mention of using insulin in type 2 patients. Then in the 90’s when glargine first came out, Sanofi worked hard to bring across the idea of resting the pancreas by starting their long acting insulin in type …

Almost 20 years ago Steve and I put out issue number one of DiabetesInControl. Things were a lot different then and we all had time to read a lot more information. About 10 years ago we started sending out a second weekly newsletter with a little different twist. This week …